ROCKWELL MEDICAL, INC. Accounts Receivable, Allowance for Credit Loss, Current
ROCKWELL MEDICAL, INC. (RMTI) had Accounts Receivable, Allowance for Credit Loss, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2025-03-20
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss, Current $0.00.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss, Current $81.00K.
- 2022-12-31: Accounts Receivable, Allowance for Credit Loss, Current $33.00K.
- 2021-12-31: Accounts Receivable, Allowance for Credit Loss, Current $16.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-20 | |
| 2023-12-31 | $81.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $33.00K 10-K · filed 2024-03-21 | |
| 2021-12-31 | $16.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $9.00K 10-K · filed 2022-04-08 | |
| 2019-12-31 | $9.00K 10-K · filed 2021-03-31 | $8.93K 10-K · filed 2020-03-17 |
| 2019-03-31 | $2.24K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.10K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $7.80K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.40K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.40K 10-Q/A · filed 2018-08-14 | |
| 2017-12-31 | $11.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $6.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $7.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $5.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $39.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $37.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $35.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $75.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | $88.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $59.00K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $53.00K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $52.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $52.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $45.00K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $41.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $37.00K 10-K · filed 2015-03-03 | |
| 2013-09-30 | $32.80K 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $32.50K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $34.60K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $26.00K 10-K · filed 2014-03-07 | |
| 2012-09-30 | $23.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $23.00K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $47.00K 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $29.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $27.00K 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $30.00K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $23.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |